Biomatrica Makes Several Key Appointments as Part of Continued G... ( SAN DIEGO Sept. 8 /...)

Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan

Date:9/8/2009

SAN DIEGO, Sept. 8 /PRNewswire/ -- Biomatrica, Inc., the leader in room temperature sample storage and stabilization, today announced several key appointments that will expand the breadth of leadership and commercial experience of its management team. This will position the company for continued rapid growth in the development and commercialization of products for the life sciences, sustainability, biobanking and forensics markets.

Martin Latterich, Ph.D., has joined the company in the role of senior director of research and development, Marylinn Munson has been appointed as vice president of business development for Biomatrica and Omoshile Clement, Ph.D., joined the company as the new marketing manager. Additionally, Francois Ferre, Ph.D. and John Thompson have been named to the company's board of directors.

"The hiring of Martin, Marylinn and Omoshile represents a critical, planned extension of our management team and provides an important foundation to our growth and progression strategy for 2009 and beyond," said Judy Muller-Cohn, CEO and co-founder of Biomatrica. "We are also pleased that Francois and John have joined the Biomatrica board of directors. Their leadership experience will be integral in the company's continued success."

About the new appointees:

Martin Latterich, Ph.D.

Dr. Latterich brings over 15 years of technical and leadership experience to Biomatrica, including expertise in growth technologies, such as proteomics, genomics, systems biology, diagnostics, personalized medicine, cell biology, protein biochemistry, and clinical sampling technologies. Dr. Latterich's previous experience includes associate professor and Tier I Canada Research Chair, McGill University and principal investigator, Montreal Proteomics Network and Pharmacogenomics Center at the University of Montreal; director, Proteomics, Illumina, Inc.; p
'/>"/>

SOURCE Biomatrica, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Biomatricas RNAstable(TM) Stabilizes RNA at Room Temperature
2. Biomatrica Introduces SampleWare(R) Version 3.0 Software for Laboratory Sample Management
3. Biomatricas PCRboost(TM) Enables 5-Fold Improvement in Amplification of Difficult Samples
4. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
5. Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage
6. Web Portal Makes Organ Donation Easy
7. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
8. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
9. Argonne researcher studies what makes quantum dots blink
10. Modifying an anti-cancer drug makes it more specific
11. NanoLogix, Inc. Makes Stock Pick List

Post Your Comments:

(Date:12/16/2009)... Special Protocol Assessment with the Food and ... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on oncology and ... its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( ... trial for perifosine (KRX-0401), the Company,s PI3K/Akt ...

(Date:12/16/2009)... Peptone. HSP A has been found to be effectinve in ... ... 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high ... and yields. HSP-A has been found to be especially effective ...

(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...

(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... - Market Forecasts to 2015, Pipeline Analysis ... http://www.reportlinker.com/p0168104/The-Future-of-Orphan-Diseases-Therapeutics---Market-Forecasts-to-2015-Pipeline-Analysis-and-Reimbursement.html ,, Summary ... latest research "The Future of Orphan Diseases ...

[0] AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma [0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement

... Mezzanine Debt Facility; Support Profitable GrowthALISO VIEJO, Calif., May ... CLRT ), a premier anatomic pathology and ... pharmaceutical industry, announced today that it has completed the ... stock with Oak Investment Partners , ...

... The Institut Pasteur and Merieux Alliance,have signed a letter ... The Institut Pasteur and Merieux Alliance ... Silliker) would like to,pool their resources and efforts to ... fields: , , - Clinical diagnostics ...

... With Movement Disorders at Home and in a Variety ... people in the US have diseases or conditions that ... traditional walking aids such as canes and walkers are ... and live independently.Now there,s a high-tech yet easy-to-use gait-training ...

Other Biology Technology:Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 2 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 3 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 4 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 5 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 6 The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 2 The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 3 Now Available: State-of-the-Art Gait Training Device to Help Millions Walk More Normally Again 2

Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases Now Available: State-of-the-Art Gait Training Device to Help Millions Walk More Normally Again

(Date:12/16/2009)... of Energy Steven Chu announced today the winners of ... in research and development supporting the Department of Energy ... will receive a gold medal, a citation and $50,000. ... in Washington, DC early next year., "The contributions made ... energy security of the United States are wide-ranging and ...

(Date:12/16/2009)... that short-term, seasonal exposure to pesticides in rivers ... of wild salmon populations. In addition to the ... that exposure to commonly used pesticides may further ... , "Major efforts are currently underway to ... recover depressed populations," says David Baldwin of the ...

(Date:12/16/2009)... 1 GestureTek Inc. today announced ... - a turnkey, portable, plug and play ... entertainment and touring promotions. GestureTek is the ... in camera-enabled gesture recognition technology for interactive ... for quality, the CUBE has TUV, CE, ...

Breaking Biology News(10 mins):Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2 Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3 Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 1 Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 2 Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 47472 3 Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 1 Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 2 Is your environment damaging your health 3F New center aims to find out 47466 1 Is your environment damaging your health 3F New center aims to find out 47466 2 Is your environment damaging your health 3F New center aims to find out 47466 3

[0] Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners [0] Even at sublethal levels, pesticides may slow the recovery of wild salmon populations [0] GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits

... Spearhead Effort in Support of "New Employee,Verification Act", ... largest,association devoted to human resource management today led ... endorse the "New Employee,Verification Act." In testimony today ... Security, Sue Meisinger, President and CEO of SHRM,urged ...

... A better understanding of brain injury, a way to ... to monitor their glaucoma at home, number among this ... day. , What surprises me every time I walk ... projects involving so many NJIT graduate and undergraduate students, ...

... . , A new brain-imaging study by researchers ... - a stomach hormone, acts on specific regions of the ... eating for pleasure. This study, published in the May ... and treating obesity, a condition affecting millions world-wide. , Appetite ...

Other Biology News:SHRM CEO Testifies Before House Subcommittee on Social Security 2 SHRM CEO Testifies Before House Subcommittee on Social Security 3 NJIT applauds students for studies on brain injury, glaucoma and more 2 Hunger hormone: Makes food more attractive 2

SHRM CEO Testifies Before House Subcommittee on Social Security NJIT applauds students for studies on brain injury, glaucoma and more Hunger hormone: Makes food more attractive

Human DEP-1/CD148 Fluorescein MAb (Clone 143-41) Protein Family: Granulocyte Markers, Monocyte Markers, Phosphatases & Regulators, Other Dendritic Cell Molecules...

MOUSE ANTI PORCINE SLA 1:FITC Immunogen: Porcine peripheral blood mononuclear cells....

NNT-1/BSF-3 (N-14)...

Monoclonal 8C2.1 is specific for Bunyavirus G1 as tested by neutralization, immunoprecipitation and immunobinding assays....

Biology Products:

Mouse Anti-Human DEP-1 / CD148 Monoclonal Antibody, Fluorescein Conjugated, Clone 143-41 from R&D Systems Mouse Anti-Porcine SLA 1 Monoclonal Antibody, FITC Conjugated from AbD Serotec Goat Anti-NNT-1/BSF-3 (N-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Anti-Bunyavirus (G1) Monoclonal Antibody, Unconjugated, Clone 8C2.1 from CHEMICON

Biomatrica Makes Several Key Appointments as Part of Continued G...( SAN DIEGO Sept. 8 /...)